Back

Everolimus-eluting bioresorabable scaffold system in the treatment of cardiac allograft vasculopathy: the cardiac allograft reparative therapy (CART) prospective multicentre pilot study

26 August 2022 (08:15 - 08:55)
Organised by:
Congress Presentation Part of: Autoimmune, chronic inflammatory disorders, HIV and cardiovascular disease Autoimmune/Chronic Inflammatory Disorders and Heart Disease ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Simone Fezzi

Verona Integrated University Hospital, Verona (Italy)

5 More presentations in this session

Presentation thumbnail
Takotsubo's cardiomyopathy in patients with pre-existing autoimmune diseases : a national inpatient sample analysis
Doctor S. Kannayiram (Chicago, US)
Abstract Slides
Presentation thumbnail
Dissecting genetics in hypothyroidism as an independent risk factor in atherosclerotic disease
Mr S. Rand (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Endothelial glycocalyx improvement after six months and one-year of antiretroviral therapy in treatment naive patients with human immunodeficiency virus
Doctor H. Triantafyllidi (Athens, GR)
Abstract Slides
Presentation thumbnail
Abnormal immune activation and fibrosis of epicardial adipose tissue in people living with HIV: results from the PIECVIH study.
Professor F. Boccara (Paris, FR)
Abstract Slides
Presentation thumbnail
Comparing cardiac MRI and lung PET/CT after completion of tuberculosis treatment - preliminary findings of participants co-enrolled into the StatinTB trial and Cardiac Imaging After TB (CIA-TB) study
Doctor S. Mukasa (Cape Town, ZA)
Abstract Slides

Access the full session

Session thumbnail
Autoimmune, chronic inflammatory disorders, HIV and cardiovascular disease

The Event

Event poster

ESC Congress 2022

26 August 2022 08:15 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources